MAPT and Alzheimer disease: For quasi quantitative analysis, we demonstrated a linear range to quantify differences in surrogate peptide abundance in AD CSF (Fig 2), but the reference standard does not accurately quantify the absolute concentration of tau based on these surrogate peptides (Fig 2A–2D).